Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Multiple Breath Washout to detect and treat pulmonary exacerbation in children with cystic fibrosis
2019-003501-10Phase 4Active
- Sponsor
- Region Västra Götaland
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin, clavulanic acid, flucloxacillin, dicloxacillin, sulfamethoxazole and 10 more in cystic fibrosis (CF) (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Lung Clearance Index (LCI). Started Apr 2020; status: active.
02
Drugs
amoxicillinclavulanic acidflucloxacillindicloxacillinsulfamethoxazole
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2019-003501-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003501-10.